Meihua International Medical Technologies Co., Ltd.
NASDAQ Global MarketRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Meihua International Medical Technologies Co., Ltd. engages in the research, development, manufacture, and sale of Class I, II, and III disposable medical devices. Its product portfolio includes Class I devices such as HDPE bottles for tablets, LDPE bottles for eye drops, throat strips, and anal bags; Class II and III devices including disposable identification bracelets, gynecological examination kits, inspection kits, surgical kits, medical brushes, medical dressings, medical catheters, uterine tissue suction tables, virus sampling tubes, disposable infusion pumps, electronic pumps, and anesthesia puncture kits. The company serves hospitals, pharmacies, medical institutions, and medical equipment companies primarily in China and exports over 120 products to more than 30 countries across Europe, North America, South America, Asia, Africa, and Oceania. Founded in 1991 and headquartered in Yangzhou, China, Meihua holds international CE certification, ISO 13485 system certification, and FDA registration for over 20 Class I products. In recent years, Meihua has focused on transforming its business towards high-end medical devices and expanding its premium medical products portfolio. Key recent developments include the construction of a medical industrial park in Hainan's Boao Hope City, ongoing since 2023 with expected completion in mid-2025, aimed at supporting minimally invasive interventional devices, new materials, and surgical robotics technologies. The company launched an AI-powered warehouse management and logistics platform called Speed Fox in May 2024 and participated in a significant milestone conducting the world’s second 5G remote robot-assisted lobectomy, demonstrating progress in robotic surgical systems development. Strategic initiatives include the sale of its Hainan Guoxie subsidiary in 2024 and securing a $6 million tranche from a securities purchase agreement to support growth. Additionally, Meihua formed a strategic partnership with Getein Biotech Inc. in 2024 to jointly produce and sell COVID-19 related medical products. The company completed a 1-for-100 reverse stock split in late 2025 to optimize share structure. Meihua International operates primarily in the medical devices industry serving diverse healthcare markets with a product range supporting infection control, surgical procedures, diagnostics, and medical supplies. It maintains a robust research and development focus, particularly in robotic-assisted surgery technologies, supported by its operations in China and expanding international footprint. Its subsidiaries include Hainan Guoxie Medical Technology Co., which was integral to its industrial park and R&D center projects in Hainan Province. The company is listed on the Nasdaq under the ticker MHUA.
Meihua International Medical Technologies (NASDAQ:MHUA) Shares Down 55.4% – Should You Sell?
Meihua International Medical Technologies, Fly-E Group And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Toll Brothers, Phreesia And 3 Stocks To Watch Heading Into Monday
Meihua International Medical Technologies Co., Ltd. Received Nasdaq Delisting Notice
Meihua International Announces 1-For-100 Reverse Share Split
Meihua International Medical Technologies Co., Ltd. Reports 2024 Financial Year Results
Meihua International Medical Technologies Co., Ltd Regains Compliance with Nasdaq Minimum Bid Price Requirement
Meihua International Medical Technologies Co., Limited Reports Unaudited 2024 First Half Financial Results
Meihua International Medical Technologies Co., Ltd. to Present at LIVE!
Meihua International Medical Technologies Facilitates World's Second* 5G Remote Robot-Assisted Lobectomy
Meihua International Medical Technologies Co., Ltd. Announces Share Repurchase Program of Up to $3 million
Meihua International Medical Technologies Co., Ltd. to Present at the Sidoti Small Cap Conference and Update Investors at the Emerging Growth Conference on June 13, 2024
Meihua International Medical Technologies Co., Ltd. to Present at the Emerging Growth Conference on May 9, 2024
Meihua International Medical Technologies Co., Ltd. Reports 2023 Financial Year Results
Meihua International Medical Technologies Co., Ltd. Announces Closing of Initial $6 Million Tranche of Potential $50.5 Million Maximum Offering
Meihua International Medical Technologies Co., Ltd. Announces Initial $6 Million Tranche of Potential $50.5 Million Maximum Offering
Meihua International Medical Technologies Co. Unveils Speed Fox, a Cutting-Edge AI-Powered Warehouse Management and Medical Device Logistics Platform
Meihua International Medical Technologies Co., Ltd. Establishes A Subsidiary Dedicated to Introducing International Patented Pharmaceuticals and Medical Device Technologies to China and Hainan Free Trade Port Boao Hope City
Meihua International Medical Technologies Co., Ltd.'s Subsidiary Officially Commences Construction of Comprehensive Medical Industrial Park in Hainan Free Trade Port Boao Hope City
Meihua International Medical Technologies Co., Ltd. Reports Unaudited 2023 First Half Financial Results